Objective Capital Management LLC Purchases New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Objective Capital Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, HoldingsChannel reports. The fund purchased 3,060 shares of the financial services provider’s stock, valued at approximately $445,000.

Other institutional investors have also bought and sold shares of the company. Jane Street Group LLC acquired a new position in iShares Biotechnology ETF in the first quarter worth $14,386,000. Cetera Investment Advisers boosted its stake in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares in the last quarter. State of Michigan Retirement System boosted its stake in iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares in the last quarter. Aristides Capital LLC acquired a new position in iShares Biotechnology ETF in the second quarter worth $9,180,000. Finally, Sanctuary Advisors LLC acquired a new position in shares of iShares Biotechnology ETF during the second quarter valued at $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.6 %

Shares of IBB traded up $0.83 during trading hours on Friday, hitting $148.85. 1,271,793 shares of the stock traded hands, compared to its average volume of 1,074,101. iShares Biotechnology ETF has a 1-year low of $113.56 and a 1-year high of $150.57. The business has a fifty day moving average of $144.84 and a 200-day moving average of $141.09.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.